Search Results - "Fukahori, M"

Implementation of a triple Gaussian beam model with subdivision and redefinition against density heterogeneities in treatment planning for scanned carbon-ion radiotherapy by Inaniwa, T, Kanematsu, N, Hara, Y, Furukawa, T, Fukahori, M, Nakao, M, Shirai, T

“…Challenging issues in treatment planning for scanned carbon-ion (C-ion) therapy are (i) accurate calculation of dose distribution, including the contribution…”
Get more information

A multicenter retrospective study of gemcitabine plus nab-paclitaxel or FOLFIRINOX in metastatic pancreatic cancer: NAPOLEON study by Nakazawa, J., Otsuka, T., Shimokawa, M., Koga, F., Ueda, Y., Otsu, S., Arima, S., Fukahori, M., Makiyama, A., Taguchi, H., Honda, T., Shibuki, T., Shirakawa, T., Mitsugi, K., Nio, K., Ide, Y., Ureshino, N.

Get full text

OC-0553: Relative risks of radiation-induced secondary cancer following particle therapy of prostate cancer by Stokkevåg, C, Fukahori, M, Nomiya, T, Matsufuji, N, Engeseth, G, Hysing, L, Ytre-Hauge, K, Szostak, A, Muren, L

Get full text

EP-1630: Estimation of the rectal and urethral NTCP parameters in carbon ion therapy for prostate cancer by Fukahori, M, Himukai, T, Matsufuji, N, Kanematsu, N, Tsuji, H, Kamada, T

Get full text

Microdosimetric evaluation of the neutron field for BNCT at Kyoto University reactor by using the PHITS code by Baba, H, Onizuka, Y, Nakao, M, Fukahori, M, Sato, T, Sakurai, Y, Tanaka, H, Endo, S

“…In this study, microdosimetric energy distributions of secondary charged particles from the (10)B(n,α)(7)Li reaction in boron-neutron capture therapy (BNCT)…”
Get full text

192P A multicenter crossover analysis of first and second-line FOLFIRINOX or gemcitabine plus nab-paclitaxel administered to pancreatic cancer patients: Results from the NAPOLEON study by Nio, K., Iguchi, H., Shimokawa, M., Shirakawa, T., Koga, F., Ueda, Y., Nakazawa, J., Komori, A., Arima, S., Fukahori, M., Makiyama, A., Taguchi, H., Honda, T., Shibuki, T., Ide, Y., Ureshino, N., Mizuta, T., Mitsugi, K., Otsuka, T.

Get full text

Effects of gastric pH on oral drug absorption: In vitro assessment using a dissolution/permeation system reflecting the gastric dissolution process by Kataoka, Makoto, Fukahori, Miho, Ikemura, Atsumi, Kubota, Ayaka, Higashino, Haruki, Sakuma, Shinji, Yamashita, Shinji

“…[Display omitted] The aim of the present study was to evaluate the effects of gastric pH on the oral absorption of poorly water-soluble drugs using an in vitro…”
Get full text

SO-1 Prognostic nomogram to predict overall survival in patients with unresectable pancreatic cancer treated with gemcitabine plus nab-paclitaxel or FOLFIRINOX: Real-world results from the multicenter retrospective study (NAPOLEON study) by Shibuki, T., Mizuta, T., Shimokawa, M., Koga, F., Ueda, Y., Nakazawa, J., Komori, A., Arima, S., Fukahori, M., Makiyama, A., Taguchi, H., Honda, T., Mitsugi, K., Nio, K., Ide, Y., Ureshino, N., Shirakawa, T., Otsuka, T.

Get full text

PD-5 Impact of biliary drainage for unresectable pancreatic cancer treated with FOLFIRINOX or gemcitabine plus nab-paclitaxel: Results from the NAPOLEON study by Honda, T., Takayuki, O., Shimokawa, M., Koga, F., Ueda, Y., Nakazawa, J., Komori, A., Arima, S., Fukahori, M., Makiyama, A., Taguchi, H., Shibuki, T., Nio, K., Ide, Y., Ureshino, N., Mitsugi, K., Otsuka, T., Shirakawa, T.

Get full text

P-88 A multicenter analysis of the correlation between overall survival and progression-free survival and the number of chemotherapeutic key drugs used in patients with advanced/unresectable pancreatic cancer: Results from the NAPOLEON study by Shirakawa, T., Ueda, Y., Shimokawa, M., Koga, F., Nakazawa, J., Komori, A., Arima, S., Fukahori, M., Makiyama, A., Taguchi, H., Honda, T., Uneda, S., Yoshida, M., Shibuki, T., Nio, K., Ide, Y., Ureshino, N., Mitsugi, K., Otsuka, T.

Get full text

Prognostic impact of the C-reactive protein/albumin ratio in advanced pancreatic cancer treated with GEM plus nab-PTX or FOLFIRINOX: Based on the results of a multicenter retrospective study (the NAPOLEON study) by Makiyama, A., Nakazawa, J., Otsuka, T., Shimokawa, M., Koga, F., Ueda, Y., Komori, A., Arima, S., Fukahori, M., Honda, T., Shibuki, T., Shirakawa, T., Nio, K., Ide, Y., Ureshino, N., Mitsugi, K.

Get full text

The importance of polymorphonuclear leukocytes in lipopolysaccharide-induced superoxide anion production and lung injury: ex vivo observation in rat lungs by Tsuji, C, Minhaz, M U, Shioya, S, Fukahori, M, Tanigaki, T, Nakazawa, H

“…The purpose of this study is to determine if the polymorphonuclear leukocyte (PMN) is a major causative agent for lipopolysaccharide (LPS)-induced lung injury…”
Get full text

P-065A multicenter retrospective study of gemcitabine plus nab-paclitaxel or FOLFIRINOX in metastatic pancreatic cancer: NAPOLEON study by Nakazawa, J, Otsuka, T, Shimokawa, M, Koga, F, Ueda, Y, Otsu, S, Arima, S, Fukahori, M, Makiyama, A, Taguchi, H, Honda, T, Shibuki, T, Shirakawa, T, Mitsugi, K, Nio, K, Ide, Y, Ureshino, N

Get full text

Association of Concomitant Coronary Artery Disease With Cardiovascular Events in Patients With Atrial Fibrillation　― The Fushimi AF Registry by Masunaga, Nobutoyo, Ogawa, Hisashi, Minami, Kimihito, Ishigami, Kenjiro, Ikeda, Syuhei, Doi, Kosuke, Hamatani, Yasuhiro, Yoshizawa, Takashi, Ide, Yuya, Fujino, Akiko, Ishii, Mitsuru, Iguchi, Moritake, Wada, Hiromichi, Hasegawa, Koji, Tsuji, Hikari, Esato, Masahiro, Abe, Mitsuru, Akao, Masaharu, on behalf of the Fushimi AF Registry Investigators

“…Background: Atrial fibrillation (AF) patients often have concomitant coronary artery disease (CAD); however, there are little data on clinical characteristics…”
Get full text

Hyperlipidemia as a risk factor for Trousseau syndrome‑related cerebral infarction in patients with advanced gastrointestinal cancer by Tanaka, Toshimitsu, Suzuki, Hiroyuki, Miwa, Keisuke, Ushijima, Tomoyuki, Nagasu, Sachiko, Fukahori, Masaru, Ishii, Kaito, Nakamura, Toru, Iwamoto, Hideki, Masuda, Atsutaka, Sakaue, Takahiko, Koga, Hironori, Akagi, Yoshito, Murotani, Kenta, Torimura, Takuji

“…Trousseau syndrome-related cerebral infarction rarely occurs during chemotherapy in patients with gastrointestinal (GI) cancer, and its clinical features…”
Get full text

Efficacy of Gemcitabine as Second-Line Therapy after Failure of S-1 Therapy for Metastatic Pancreatic Carcinoma by Fukahori, M., Kondo, S., Ueno, H., Shimizu, S., Mitsunaga, S., Ikeda, M., Yamaguchi, T., Sakamoto, Y., Morizane, C., Okusaka, T.

Get full text

Phase II Study of Weekly Paclitaxel as a Second-line Treatment for S-1-refractory Advanced Gastric Cancer by MATSUDA, Goro, KUNISAKI, Chikara, KOSAKA, Takashi, ONO, Hedetaka A, AKIYAMA, Hirotoshi, ICHIKAWA, Yasushi, MAKINO, Hirochika, FUKAHORI, Michiko, KIMURA, Jun, SATO, Tsutomu, OSHIMA, Takashi, NAGANO, Yasuhiko, FUII, Shoichi, TAKAGAWA, Ryo

“…Background: We retrospectively evaluated the efficacy of weekly paclitaxel therapy as second-line treatment for patients with advanced gastric cancer that was…”
Get full text

Monoaminergic regulation of the levels of beta-endorphin-like immunoreactivity (beta-ENDi) in rat hypothalamic nuclei by Nohtomi, A, Itoh, M, Yufu, N, Fukahori, M, Kawasaki, H

“…To examine the role of monoamines in regulating beta-endorphin levels in discrete brain nuclei, the levels of beta-endorphin-like immunoreactivity (beta-ENDi)…”
Get more information

Inhibition of xanthine oxidase and xanthine dehydrogenase by nitric oxide. Nitric oxide converts reduced xanthine-oxidizing enzymes into the desulfo-type inactive form by Ichimori, K, Fukahori, M, Nakazawa, H, Okamoto, K, Nishino, T

“…Xanthine oxidase (XO) and xanthine dehydrogenase (XDH) were inactivated by incubation with nitric oxide under anaerobic conditions in the presence of xanthine…”
Get full text

Results of annual health examination for the aged provided by the law that are predictive of increased mortality risk by Iwata, K, Yamasaki, T, Saito, H, Ito, S, Fukahori, M, Nakazato, T, Nagao, S

“…Possible risk factors associated with mortality were studied in a community using data derived from annual mass health examinations for the aged mandated by…”
Get more information